CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
84 hedge funds and large institutions have $29.5M invested in Carisma Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
48% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 31
Holders
84
Holding in Top 10
–
Calls
$934K
Puts
$1.12M
Top Buyers
| 1 | +$412K | |
| 2 | +$276K | |
| 3 | +$198K | |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$59.2K |
| 5 |
State Street
Boston,
Massachusetts
|
+$31.5K |
Top Sellers
| 1 | -$407K | |
| 2 | -$404K | |
| 3 | -$350K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$308K |
| 5 |
Two Sigma Advisers
New York
|
-$288K |